Manuscripts
Showing 1551 manuscripts.
Etravirine Pharmacokinetics in HIV-Infected Pregnant Women
Citation
Brookie M Best, Edmund V Capparelli, Alice M Stek, Courtney V Fletcher, Angela Colbers, Jiajia Wang, Jose Molto, Graham Taylor, Elizabeth Smith, Carmen Hidalgo Tenorio, Nahida Chakhtoura, Marjo Van Kasteren, Mark Mirochnick, David Burger, Nikki Mulligan, Stein Schalkwijk. Etravirine Pharmacokinetics in HIV-Infected Pregnant Women. Frontiers in Pharmacology. 2016. 7: 239. PMID: 27540363Year
2016
Journal
Frontiers in Pharmacology
Study
P1026S
Risk of congenital cytomegalovirus infection among HIV-exposed uninfected infants is not decreased by maternal nelfinavir use during pregnancy.
Citation
Denise L Jacobsen, Isabelle Boucioran, Meei-Li Huang, Keith R Jerome, Gonzague Jourdain, Nicole Ngo-Giang-Huong, Sandra Burchett, Lisa Frenkel, Soren Gantt, Erin Leister. Risk of congenital cytomegalovirus infection among HIV-exposed uninfected infants is not decreased by maternal nelfinavir use during pregnancy.. Journal of Medical Virology. 2016. 88: 1051-8. PMID: 26519647Year
2016
Journal
Journal of Medical Virology
Development and validation of an oligonucleotide ligation assay to detect lamivudine resistance in hepatitis B virus
Citation
N Ngo-Giang-Huong, W Khamduang, L Laomanit, G Jourdain, L Frenkel, IA Beck, R Payant. Development and validation of an oligonucleotide ligation assay to detect lamivudine resistance in hepatitis B virus. Journal of Virological Methods. 2016. 233: 51-55. PMID: 27025356Year
2016
Journal
Journal of Virological Methods
Comparison of matrix-based and filter paper-based systems for transport of plasma forHIV-1 RNA quantification and amplicon preparation for genotyping.
Citation
S Styrchak, G Pepper, L Frenkel, M Levine, I Beck. Comparison of matrix-based and filter paper-based systems for transport of plasma forHIV-1 RNA quantification and amplicon preparation for genotyping.. Journal of Clinical Microbiology. 2016. 54: 1899-1901. PMID: 27076660Year
2016
Journal
Journal of Clinical Microbiology
Early Combination Antiretroviral Therapy Limits Exposure to HIV-1 Replication and Cell-Associated HIV-1 DNA Levels in Infants
Citation
R Hudson, LM Mofenson, JL Sullivan, M Somasundaran, K Luzuriaga, PACTG 356 Investigators, M McManus, E Mick. Early Combination Antiretroviral Therapy Limits Exposure to HIV-1 Replication and Cell-Associated HIV-1 DNA Levels in Infants. PLoS One. 2016. 11: e0154391. PMID: 27104621Year
2016
Journal
PLoS One
Alteration in cytochrome P450 3A4 activity as measured by a urine cortisol assay in HIV-1-infected pregnant women and relationship to antiretroviral pharmacokinetics
Citation
L Huang, BM Best, A Stek, P Lizak, SK Burchett, JS Read, H Watts, M Mirochnick, EV Capparelli, IMPAACT P1026s Protocol Team, FT Aweeka, C Hu. Alteration in cytochrome P450 3A4 activity as measured by a urine cortisol assay in HIV-1-infected pregnant women and relationship to antiretroviral pharmacokinetics. HIV Medicine. 2015. 16: 176-183. PMID: 25407158Year
2015
Journal
HIV Medicine
Study
P1026S, P1026S
Pharmacokinetics of tenofovir during pregnancy and postpartum
Citation
H Li, A Stek, C Hu, J Wang, E Hawkins, M Byroads, DH Watts, E Smith, CV Fletcher, EV Capparelli, M Mirochnick, IMPAACT P1026s Team, BM Best, S Burchett. Pharmacokinetics of tenofovir during pregnancy and postpartum. HIV Medicine. 2015. 16: 502-511. PMID: 25959631Year
2015
Journal
HIV Medicine
Study
P1026S, P1026S
Impact of body weight and missed doses on lopinavir concentrations with standard and increased lopinavir/ritonavir doses during late pregnancy
Citation
Edmund V. Capparelli, Boonsong Rawangban, Prapan Sabsanong, Brookie M. Best, Sudanee Buranabajasatean, Aram Limtrakul, Jean-Marc Treluyer, Gonzague Jourdain, Alice Stek, Marc Lallemant, Mark Mirochnick, Tim R Cressey, Saik Urien. Impact of body weight and missed doses on lopinavir concentrations with standard and increased lopinavir/ritonavir doses during late pregnancy. Journal of Antimicrobial Chemotherapy. 2015. 70: 217-224. PMID: 25261418Year
2015
Journal
Journal of Antimicrobial Chemotherapy
Study
P1026S
Infant HIV Type 1 gp120 vaccination Elicits Robust and Durable Anti-V1V2 Immunoglobulin G responses and only Rare Envelope-Specific Immunoglobulin A Responses
Citation
S Nitayaphan, E McFarland, J Kaewkungwal, B Borkowsky, P Muresan, S Rerks-Ngarm, J Pollara, H-X Liao,, L Y Song, B Haynes, B Liebl, D Montefiori, K Whitaker, G Ferrari, X Shen, G Tomaras, N Vandergrift, S Permar, RG Overman, N Yates, A Moody, C Fry, J Kim, Genevieve Fouda, N Michael, Coleen Cunningham, P Pitisuttithum. Infant HIV Type 1 gp120 vaccination Elicits Robust and Durable Anti-V1V2 Immunoglobulin G responses and only Rare Envelope-Specific Immunoglobulin A Responses. Journal of Infectious Diseases. 2015. 211: 508-517. PMID: 25170104Year
2015
Journal
Journal of Infectious Diseases